RAFFA WEALTH MANAGEMENT, LLC’s Krystal Biotech KRYS Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743	Buy	+2	New	+$598	﹤0.01%	1107

Other funds holding KRYS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's KRYS Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC opened a new position in Krystal Biotech (KRYS) in Q2 2026: 2 shares worth $743. The stake represents ﹤0.01% of the portfolio and ranks #1107 among its holdings.

97 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 2 shares of Krystal Biotech worth $743 as of Q2 2026.
Krystal Biotech was a new RAFFA WEALTH MANAGEMENT, LLC position in Q2 2026.
Krystal Biotech made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1107 holding.
97 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.